Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

Events and presentations

Events and presentations

Upcoming events
More events are coming soon.
Past events

Nov 21, 2024 at 12:00 PM GMT

Nov 18, 2024 at 10:20 AM EST

Oct 30, 2024 at 8:00 AM EDT

Sep 20, 2024 at 11:00 AM EDT

Please visit Publications & Presentations to find our most recent data presentations.